Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2018
Total Assets: $60.68B
Liabilities Breakdown FY2018
Total Liabilities: $44.89B
Asset Breakdown
Total Assets: $60.68B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.78B | 2.9% |
| Accounts Receivable | $5.82B | 9.6% |
| Inventory | $4.73B | 7.8% |
| Property, Plant & Equipment | $6.87B | 11.3% |
| Goodwill | $24.92B | 41.1% |
| Intangible Assets | $14.01B | 23.1% |
| Other Assets | $2.56B | 4.2% |
Liabilities Breakdown
Total Liabilities: $44.89B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $44.89B | 100.0% |